Resumo

GARCIA FARINAS, Anaí; FARINAS REINOSO, Ana Teresa  e  GALVEZ, Ana María. Uso del meprobamato en el tratamiento de la hipertensión arterial: Consecuencias económicas. Rev Cubana Farm [online]. 2002, vol.36, n.3, pp. 157-161. ISSN 1561-2988.

The hypertensive population taking meprobamate as part of the arterial hypertension treatment was characterized and the economic effect of this inadequate therapy for the individual and for the society was calculated. 27 patients over 15 that were treated with this drug were studied. 40.7 % of these patients referred to unappropriated therapeutic properties of this drug as hypotensive. The impossibility to have the drug influenced on the quality of life of the patients. 51.8 % felt uncontrolled when they could not take the drug. Every patient spent between $1.60 and $40.00 a month, depending on the way of acquisition. As a result of the research, it was concluded that the inadequate administration of meprobamate as a hypotensive agent brings about an unnecessary drug dependance that together with the increase of the production demand in the industrial setting, provoke the utilization of resources in its production and affect other options.

Palavras-chave : MEPROBAMATE [therapeutic use]; HYPERTENSION [drug therapy]; COST OF ILLNESS; EXPENDITURES; DRUGS USE HABITS.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )